Very Low Tumor Mutation Burden Identifies Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy

Request Access

Recurrent Glioblastoma Treated with Recombinant Poliovirus

A. Desjardins, M. Gromeier, J. Herndon, et al.. (2018). The New England Journal of Medicine. Cited 658 times. https://doi.org/10.1056/NEJMoa1716435

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

M. Gromeier, Michael C. Brown, Gao Zhang, et al.. (2021). Nature Communications. Cited 105 times. https://doi.org/10.1038/s41467-020-20469-6
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747